Safety and efficacy of ophthalmic mitochondrial reactive oxygen species scavenger Visomitin for the treatment of dry eye disease: findings of VISTA-1 and VISTA-2 studies

Visomitin (plastoquinonyl decyl triphenylphosphonium) - Mitotech, BIO invest

https://arvo2022.arvo.org/meetings/A4BkHMwS8agjMfs72

George Ousler; Michael Watson; John Sheppard; Paul Karpecki; Lawrence Friedhoff; Anton Petrov; Maxim Skulachev; Malcolm Ngiam; Quinn Xue

Apr 29, 2022